Home > Healthcare > Medical Devices > Diagnostic Devices > Coronary Heart Disease Diagnostic Imaging Devices Market

Coronary Heart Disease Diagnostic Imaging Devices Market Share

Report ID: GMI11128
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Coronary Heart Disease Diagnostic Imaging Devices Market Share

The coronary heart disease diagnostic imaging devices industry is characterized by intense competition, involving both major global companies and smaller to medium-sized firms vying for market dominance. Key to market strategy is the consistent launch of innovative products utilizing various technologies. Major industry leaders play a significant role in driving innovation through substantial investments in research and development. Moreover, strategic partnerships, acquisitions, and mergers are crucial in strengthening market positions and enhancing international presence.

Coronary Heart Disease Diagnostic Imaging Devices Market Companies

Some of the eminent market participants operating in the market industry include:

Canon Inc.
Carestream Health
CHISON Medical Technologies Co., Ltd.
Esaote SPA
FUJIFILM Holdings Corporation
GE HealthCare Technologies Inc.
Koninklijke Philips N.V.
Neusoft Corporation
Samsung Electronics Co., Ltd.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Shimadzu Corporation
Siemens Healthineers AG
Ziehm Imaging GmbH.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Coronary heart disease diagnostic imaging devices industry size was valued at around USD 1.8 billion in 2023 and is estimated to record a 6.6% CAGR from 2024 to 2032, due to increasing prevalence of coronary heart disease.

The computed tomography segment of market is predicted to reach USD 443.8 million by 2032, as CT scans offer high-resolution imaging that is crucial for visualizing the coronary arteries and detecting blockages or narrowing with major detail.

The coronary heart disease diagnostic imaging devices market value in the U.S. is projected to reach USD 1.3 billion by 2032, as coronary heart disease remains a leading cause of death in the U.S. due to aging, poor diet, lack of physical activity, and smoking.

CHISON Medical Technologies Co., Ltd., Esaote SPA, FUJIFILM Holdings Corporation, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Neusoft Corporation, Samsung Electronics Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and Shimadzu Corporation among others.